Industry News

Vitality Biopharma, Inc., a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to announce that effective immediately, its common stock now trades on the over-the-counter market under the symbol "VBIO." Trading of the company's stock under the new symbol represents the completion of the company's..."/>
Vitality Biopharma Begins Trading Under New Stock Symbol "VBIO"
Juno Therapeutics, Inc. shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’ s securities between June 4, 2016 through July 7, 2016, inclusive. REMINDER: Juno shareholders who purchased their securities during the Class Period may, no later than September 12, 2016, petition the Court to be appointed as a lead plaintiff representative of the class. For additional..."/>
SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Juno Therapeutics, Inc.
Endologix, Inc., developer and marketer of innovative treatments for aortic disorders, announced today the first two patients with abdominal aortic aneurysms have been treated with the Ovation Alto™ Abdominal Stent Graft System. The patients were treated by Andrew Holden, MD, and Andrew Hill, MD, of Auckland City Hospital, Auckland, New Zealand.."/>
Endologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System
Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company focused on late stage drug development, today issued its financial reports for the first half of 2016, ending June 30, 2016.. "We have advanced according to plan in the clinical, chemistry, regulatory, and intellectual property areas of KIT-302's development," remarked Kitov's CEO, Isaac Israel."/>
Kitov Pharmaceuticals Issues First Half 2016 Financial Reports
BriaCell Therapeutics Corp. is pleased to announce that Dr. Jarrod P. Holmes, a Board Certified Oncologist and a leading expert in breast cancer vaccines at Annadel Medical Group and St."/>
BriaCell Appoints the Lead Principal Investigator and First Clinical Site for Its Upcoming Phase I/IIa Clinical Trial in Advanced Breast Cancer
Trovagene, Inc., a developer of circulating tumor DNA molecular diagnostics, announced today that it has signed an in-network provider agreement with the healthcare network Blue Cross Blue Shield of Illinois establishing health benefit access to the full line of Trovagene's tests and services. "The agreement with BCBSIL takes us a step further in the execution of our access and reimbursement strategy that includes establishing..."/>
Blue Cross Blue Shield Illinois to Cover Trovera™ Liquid Biopsy Tests
WellCare Health Plans, Inc., is working to raise awareness of teen pregnancy prevention in Burke County, Georgia. WellCare's CommUnity Advocacy team launched the Burke County Health Connections council with local community partners to address barriers to social services."/>
WellCare Addresses Teen Pregnancy in Burke County, Georgia
Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reminded its customers that the Henry Schein Disaster Relief Hotline is open for dentists, physicians and veterinarians who experience operational, logistical or financial issues as a result of the flooding in southeastern Louisiana. The toll-free number for all Henry Schein..."/>
Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Flooding In Louisiana
WAVE Life Sciences Ltd., a genetic medicines company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases, today announced that it has appointed Keith Regnante as the company’ s Chief Financial Officer. Regnante will provide strategic direction and bring substantial management experience to WAVE’ s finance and operations functions. “We are thrilled to have Keith join us at this exciting time in WAVE’ s history, as we..."/>
WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer
HealthSouth Corporation today announced it will participate in the following investor conferences in September 2016:. Sept. 7, 2016, HealthSouth Executive Vice President and Chief Operating Officer Mark Tarr, and Executive Vice President and Chief Financial Officer Doug Coltharp, will participate in a fireside chat at 8:30 a.m. ET at the Baird Healthcare Conference held at the New York Palace Hotel in New York. Sept. 8, 2016, Tarr and..."/>
HealthSouth To Present At Investor Conferences In September
MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug development company announces that the Company's common stock will begin trading on The Nasdaq Capital Market under the stock symbol MBVX effective with the market open today. The Company also announces the pricing of a public offering. The offering consists of $8.625 million of common stock and Series F Preferred Stock at $4.81 per share of common stock or Series F Preferred..."/>
MabVax Therapeutics Announces Uplisting to The Nasdaq Capital Market and $8.625 million Public Offering
BioSig Technologies, Inc., a medical device company developing the PURE EP (TM) System, a novel cardiac electrophysiology information system, today announced its submission entitled“ Enhanced Electrophysiology Recording System” will be presented on Friday, August 19, 2016 at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. The presentation will be held in Pastoral 1 at the Contemporary Resort in..."/>
BioSig Achieves Important Technical Milestone
Innocoll Holdings plc, a global, specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical needs, today announced financial and operating results for the three months and six months ended June 30, 2016. Using our proprietary collagen-based technology platform, we manufacture and supply a range of biodegradable and fully bioresorbable pharmaceutical products and medical devices..."/>
Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update
Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc., will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight. "I am thrilled to once again be working alongside Samira as, even after 14 years together at Paladin, I continue to learn from..."/>
A Knight is Reborn
InVivo Therapeutics Holdings Corp. today announced that the ninth patient implanted with the Neuro-Spinal Scaffold™ in the INSPIRE study has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury in the time between the two- and three-month evaluations. This is the fifth out of the eight patients in follow-up to have had an AIS grade improvement to..."/>
InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™
Audentes Therapeutics, Inc., a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today reported that the first patient has been enrolled in INCEPTUS, a prospective study designed to characterize the disease presentation in children living with X-Linked Myotubular Myopathy. The study is evaluating subjects prior to potential..."/>
Audentes Therapeutics Announces First Patient Enrolled in the INCEPTUS Clinical Assessment Study of XLMTM
Monster Worldwide Inc., Robert Half International Inc., ManpowerGroup Inc., and Team Health Holdings Inc.. Investment firm Jefferies is bullish on the sector due to growing demand for outsourcing solutions despite structural labor shortages."/>
Staffing & Outsourcing Services Stocks Technical Reports -- Monster Worldwide, Robert Half Intl., ManpowerGroup, and Team Health
Perrigo Company plc announced today that it has agreed to acquire Peachtree City, Georgia-based, Geiss, Destin& Dunn, Inc., a small national distributor of over-the-counter healthcare and consumer goods products to the non-chain retail and institutional markets. The transaction is expected to close by the end of August. Perrigo CEO John T. Hendrickson commented, "Today's acquisition of GDD, while relatively small in transaction value compared to..."/>
Perrigo to Acquire U.S. Distributor of Healthcare & Consumer Goods Products, Geiss, Destin & Dunn
Zynga Inc., MGT Capital Investments Inc., Activision Blizzard Inc., and Electronic Arts Inc.."/>
Multimedia & Graphics Software Stocks Under Review -- Zynga, MGT Capital Investments, Activision Blizzard, and Electronic Arts

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary626 Articles
Information Technology592 Articles
Financials504 Articles
Health Care362 Articles
Industrials352 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.